U.S. Mortgage Finance Stock News

NYSE:PL
NYSE:PLProfessional Services

Planet Labs (PL) Is Down 29.5% After Launching US$1.5 Billion ATM Offering And Raising Guidance

In early June 2026, Planet Labs PBC reported first-quarter revenue of US$94.15 million versus US$66.27 million a year earlier, alongside a net loss of US$138.87 million and filed a new shelf registration for an at-the-market follow-on equity offering of up to US$1.50 billion in Class A common stock. At the same time, Planet advanced its Pelican satellite roadmap with the Pelican-11 tech demonstrator and issued stronger revenue guidance, highlighting a business balancing heavy investment,...
NasdaqGM:ALNT
NasdaqGM:ALNTElectrical

The Bull Case For Allient (ALNT) Could Change Following Mixed Q1 Results And Strong Booking Trends

In early June 2026, Allient reported Q1 revenue growing 4.6% year on year in line with expectations, even as EBITDA and EPS came in below analyst estimates. Management’s emphasis on strong booking growth and alignment with long-term electrification and automation trends has coincided with rising hedge fund interest, even as some investors trim positions amid earnings sustainability concerns. We’ll now examine how Allient’s recent booking strength and focus on electrification and automation...
NYSE:RGA
NYSE:RGAInsurance

A Look At Reinsurance Group of America (RGA) Valuation As Shares Tread Water After Recent Moves

Recent performance and what has caught investors’ attention Reinsurance Group of America (RGA) has drawn fresh interest after recent share price moves, with the stock ending the latest session at US$201.21 and sitting slightly down year to date. Short term returns have been mixed, with the stock down about 2% over the past week, down roughly 4% over the past month, and lower by around 3% over the past 3 months, while the 1 year total return is slightly positive. See our latest analysis for...
NasdaqGS:ZVRA
NasdaqGS:ZVRAPharmaceuticals

Does Zevra Therapeutics (ZVRA) Patent Push and Board Structure Signal a Shifting Risk Profile?

Zevra Therapeutics recently disclosed that shareholders at its June 4, 2026 annual meeting rejected an amendment to phase out the company’s classified board structure, which would have shifted all directors to one-year terms beginning with the 2027 annual meeting. Around the same time, Zevra moved to strengthen its intellectual property position by asking the U.S. Food and Drug Administration to list a new MIPLYFFA patent in the Orange Book, aiming to extend patent protection to 2041 and...
NasdaqGS:FLNC
NasdaqGS:FLNCElectrical

A Look At Fluence Energy (FLNC) Valuation After The Siemens And Nvidia AI Data Center Collaboration

Fluence Energy (FLNC) has been in focus after its collaboration with Siemens and Nvidia to design AI data centers that use Fluence battery storage. This move ties the stock to growing AI power demand. See our latest analysis for Fluence Energy. After a sharp run that has lifted the 1 year total shareholder return to a very large gain of about 7x, recent trading has been choppy. The 90 day share price return is 42.6%, while the 7 day share price return is a weaker 11.3% and the 30 day share...
NYSE:EMN
NYSE:EMNChemicals

Evaluating Eastman Chemical (EMN) After Recent Share Price Momentum And Perceived Valuation Discount

Recent performance snapshot With no single headline event driving Eastman Chemical (EMN) today, investors are focusing on how the stock has moved recently and how that lines up with the company’s latest financial profile. See our latest analysis for Eastman Chemical. At a share price of US$71.67, Eastman Chemical has given investors a year to date share price return of 11.39%, while the 1 year total shareholder return is down 5.95%. This suggests that recent momentum has improved compared...
NYSE:MCK
NYSE:MCKHealthcare

Analysts’ Backing of 2027 Targets Might Change The Case For Investing In McKesson (MCK)

In recent days, McKesson reported a mixed quarter but reinforced its long‑term plans, while major Wall Street banks reaffirmed positive views on the company’s outlook and multi-year guidance. At the same time, ongoing insider share sales and assessments of the stock as modestly overvalued have sharpened investor focus on how credible its fiscal 2027 ambitions really are. We’ll now examine how analysts’ support for McKesson’s fiscal 2027 guidance could influence the company’s existing...
NasdaqGS:CRNX
NasdaqGS:CRNXPharmaceuticals

A Look At Crinetics Pharmaceuticals (CRNX) Valuation After Recent Share Price Weakness

Crinetics Pharmaceuticals (CRNX) has drawn investor attention after recent trading, with the stock closing at US$33.48 and showing mixed short term performance, including a decline of around 11% over the past month. See our latest analysis for Crinetics Pharmaceuticals. Recent price weakness, including a 30 day share price return of around 11% down and a year to date share price return of around 28% down, contrasts with a 1 year total shareholder return of 3.7% and a 3 year total shareholder...
NYSE:KGS
NYSE:KGSEnergy Services

A Look At Kodiak Gas Services (KGS) Valuation After Jefferies Coverage And Planned Public Share Offering

What sparked fresh interest in Kodiak Gas Services? Recent attention on Kodiak Gas Services (KGS) was kicked off by new analyst coverage from Jefferies, along with the company’s plan to sell over 10 million shares through an underwritten public offering priced at US$71. See our latest analysis for Kodiak Gas Services. Those announcements have come during a strong run, with the share price at US$67.63 after a 3.87% 1 day share price return and 79.68% year to date share price return. The 1 year...
NYSE:HP
NYSE:HPEnergy Services

How Investors Are Reacting To Helmerich & Payne (HP) Dividend, Asset Sale and Caspian Contract Renewal

Helmerich & Payne’s board on June 3, 2026, declared a quarterly cash dividend of US$0.25 per common share, payable on September 1 to shareholders of record as of August 18, alongside reporting a fiscal second-quarter net loss influenced by a non-cash impairment. The company also exceeded its asset divestiture goal with the sale of the Utica Square retail center and renewed a major Caspian Sea offshore operations and maintenance contract through its TURAN joint venture, reinforcing its focus...
NYSE:NOC
NYSE:NOCAerospace & Defense

If SpaceX’s Trillion Valuation Hits, These Space Giants Suffer

The SpaceX IPO hype is not just about one company; it is reshaping attention and capital around space and AI, and that can create both openings and pressure points for other stocks. With a US$75 billion offer for 5% of the company and a US$1.75 trillion valuation tied closely to its xAI ambitions, investors are suddenly rethinking which companies might lose out as money and headlines gravitate toward this new listing. This article highlights 3 stocks exposed to that news, each at risk of...
NasdaqGS:VRNS
NasdaqGS:VRNSSoftware

A Look At Varonis Systems (VRNS) Valuation As Shares Show Mixed Recent Performance

Stock performance snapshot Varonis Systems (VRNS) has seen mixed share performance recently, with a gain of around 1% over the past day and a decline of about 8% over the past week. Over the past month the stock is up roughly 16%, while the past 3 months show a gain of about 38%. Over the past year, however, the stock is down around 35%. See our latest analysis for Varonis Systems. At a share price of $33.04, Varonis Systems has recently shown firm short term share price momentum, with a 30...
NasdaqGS:WERN
NasdaqGS:WERNTransportation

What Werner Enterprises (WERN)'s Earnings Slide and Value-Destructive Investments Mean For Shareholders

Werner Enterprises recently reported that sales have fallen for two consecutive years and earnings per share have dropped sharply, underscoring difficult end-market conditions and pressure on profitability. Management’s recent capital investments are currently destroying value rather than enhancing returns, raising questions about how effectively Werner is deploying resources in a challenging freight market. We’ll now examine how Werner’s recent earnings decline and value-destructive...
NasdaqGS:VRTX
NasdaqGS:VRTXBiotechs

Vertex Extends Cystic Fibrosis Reach With Pediatric ALYFTREK And TRIKAFTA Data

Vertex Pharmaceuticals (NasdaqGS:VRTX) reported new clinical data for its next-generation cystic fibrosis therapy ALYFTREK in young children. The company also outlined progress on global regulatory submissions for ALYFTREK and TRIKAFTA in pediatric populations. The updates focus on expanding treatment access to children as young as 2 years old and on long term safety findings in older patients. Vertex Pharmaceuticals sits at the center of the cystic fibrosis treatment market, and the latest...
NYSE:PSN
NYSE:PSNProfessional Services

How New AI‑Driven Air Force Software Awards Could Shape Parsons (PSN) Defense Tech Narrative

In early June 2026, Parsons Corporation announced multiple wins under the U.S. Air Force’s GARDEM 2 program, including a US$99 million, five-year-plus task order for advanced command‑and‑control and ISR software and a US$28 million, five-year field site support contract, while also highlighting its growing use of embedded AI across federal and infrastructure projects. These awards reinforce Parsons’ position as a key technology partner on mission‑critical defense and infrastructure programs,...
NasdaqGS:PZZA
NasdaqGS:PZZAHospitality

A Look At Papa John’s (PZZA) Valuation As Toy Story 5 Partnership And AI Ordering Rollout Take Shape

Toy Story 5 tie up puts Papa John's marketing and digital push in focus Papa John's International (PZZA) is leaning on a new global Toy Story 5 collaboration, complete with themed menus, collectibles, pop ups and an AI ordering assistant, to sharpen its brand and digital reach. See our latest analysis for Papa John's International. The Toy Story 5 campaign and Lou AI launch arrive at a time when Papa John’s share price return has fallen 21.46% year to date and the 1 year total shareholder...
NYSE:WEX
NYSE:WEXDiversified Financial

Should Forbes Culture Win and Fuel-Sensitive Mobility Exposure Require Action From WEX (WEX) Investors?

In early June 2026, WEX was named one of America’s Best Employers for Company Culture by Forbes, ranking 78th overall and first among Maine-based companies, reflecting its emphasis on workplace culture, AI-enabled employee programs, and benefits. Alongside this culture recognition, analysts have highlighted WEX’s exposure to mobility and payments and its sensitivity to elevated fuel prices as a potentially important driver of future earnings performance. Next, we’ll examine how WEX’s culture...
NYSE:GPOR
NYSE:GPOROil and Gas

Did Gulfport’s New CEO and Board Expansion Just Reframe GPOR’s Capital Allocation Narrative?

On May 28, 2026, Gulfport Energy Corporation expanded its Board to seven members and appointed Domenic J. Dell’Osso, Jr. as President, Chief Executive Officer, and director, with his Board term running until the 2027 Annual Meeting of Stockholders or until a successor is elected and qualified. Investors may focus on Dell’Osso’s prior leadership of Expand Energy Corporation, where he emphasized capital efficiency, disciplined capital allocation, and shareholder returns, as they assess how his...
NasdaqGS:PHVS
NasdaqGS:PHVSPharmaceuticals

Why Pharvaris (PHVS) Is Up 8.6% After Expanding Deucrictibant HAE Data And Regulatory Plans

Pharvaris has recently highlighted its hereditary angioedema program, announcing multiple deucrictibant data presentations at upcoming scientific congresses and confirming preparations for marketing authorization applications alongside ongoing global Phase 3 trials for both on-demand and prophylactic use. An interesting angle for investors is the breadth of data being shared, from cardiovascular safety and biomarker assays to long-term quality-of-life outcomes, which gives a more...
NasdaqGS:LULU
NasdaqGS:LULULuxury

lululemon athletica (LULU) Is Down 11.0% After Outlook Cut And Founder Deal - Has The Bull Case Changed?

In early June 2026, lululemon athletica reported first‑quarter sales of US$2,471.6 million with significantly lower net income and earnings per share than a year earlier, cut its full‑year outlook, and issued guidance for a 2%–3% revenue decline in the second quarter alongside ongoing U.S. demand and margin pressures. At the same time, the company moved to resolve tensions with founder Chip Wilson through a cooperation agreement that reshapes its board and governance, while management...
NYSE:TUYA
NYSE:TUYASoftware

Assessing Tuya (TUYA) Valuation As It Pivots Toward AI Software And Hardware

Recent attention on Tuya (TUYA) has been driven by its pivot toward AI integrated software and AI enabled consumer hardware, as investors weigh the potential of its PaaS and AI applications segments. See our latest analysis for Tuya. Despite the buzz around Tuya’s AI focused PaaS and hardware ambitions, the stock has retreated, with the 30 day share price return down 22.18% and the 1 year total shareholder return down 29.02%. This suggests recent enthusiasm has cooled after earlier multi year...
NYSE:CUZ
NYSE:CUZOffice REITs

Cousins Properties (CUZ) Valuation After Buyback Expansion Oracle Lease And Higher 2026 Guidance

Cousins Properties (CUZ) has been in focus after management expanded its share buyback program to $500 million, secured a long-term Oracle lease at Neuhoff, and raised 2026 FFO guidance on higher leasing assumptions. See our latest analysis for Cousins Properties. The recent buyback expansion and Oracle lease come against a backdrop of stronger momentum, with the share price up 22.0% over 90 days and a 3 year total shareholder return of 53.7%, even though the latest price of $28.32 leaves the...
NYSE:MO
NYSE:MOTobacco

How Altria’s Earnings Beat and Higher Outlook Will Impact Altria Group (MO) Investors

In recent weeks, Altria Group reported quarterly earnings and revenue that came in above analyst expectations, while modestly raising its earnings forecasts and reaffirming full-year guidance. This combination of an earnings beat and a slightly improved outlook has increased investor attention on how effectively Altria can grow its smoke-free business alongside its traditional tobacco operations. With that backdrop, we’ll now explore how Altria’s better-than-expected results and firmer...
NYSE:TAP
NYSE:TAPBeverage

A Look At Molson Coors (TAP) Valuation After Recent Share Weakness And Forecasts For A Return To Profit

Recent share performance and what it might signal Molson Coors Beverage (TAP) has drawn attention after a mixed run in its share performance, with the stock up about 1% over the past week but down over the past month and past 3 months. Over the past year, the stock has fallen about 21%, with year to date performance also lower. The company reports annual revenue of US$11.19b and a net loss of US$2.11b, giving investors a contrasting set of signals to weigh. See our latest analysis for Molson...